首页> 美国卫生研究院文献>Cancers >Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival
【2h】

Medullary Thyroid Cancer in Patients Older than 45—Epidemiologic Trends and Predictors of Survival

机译:髓质甲状腺癌患者患者超过45个流行病学趋势和存活者的预测因素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sporadic medullary thyroid cancer can occur anytime in life although they tend to present at a later age (≥45 years old) when the tumors are more easily discernible or become symptomatic. We present, in this study, a group of patients diagnosed with medullary thyroid cancer at or after 45 years of age when they are more likely to develop sporadic forms of medullary thyroid cancer with regard to their natural history and prognosis. In this study, we evaluated factors affecting survival in such patients. We found that the incidence of medullary thyroid cancer in patients ≥45 years of age is increasing. Our findings suggest that patients should be offered surgical resection at an early stage to improve their outcomes.
机译:孢子加长髓质甲状腺癌可以随时发生寿命,尽管当肿瘤更容易辨别或症状时,它们往往呈现在后期(≥45岁)。我们在这项研究中存在,一组患者在45岁时被诊断出患有髓质甲状腺癌的患者,当他们更有可能在自然历史和预后开发孢子形式的甲状腺癌。在这项研究中,我们评估了影响这些患者存活的因素。我们发现,≥45岁的患者中髓质甲状腺癌的发病率正在增加。我们的研究结果表明,患者应在早期阶段提供手术切除,以改善其结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号